SavedAdd your journal

Journals / Eurasian Dental Research / 2026 / Volume: 4 Issue: 2

Chemotherapy-Associated Osteonecrosis of the Jaw in Acute Lymphoblastic Leukemia: Report of a Rare Clinical Case

Gülsün Aydoğmuş(BIRUNI UNIVERSITY, FACULTY OF DENTISTRY)0000-0002-9931-0628
Fatma Büşra Akgül(BIRUNI UNIVERSITY, FACULTY OF DENTISTRY)0000-0002-9229-1559
Elaheh Nasiri(BİRUNİ ÜNİVERSİTESİ)0009-0006-7782-4181
Pages
—
Publication Date
2026-08-03
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Surgical management with adjunctive PRF may enhance healing outcomes in such cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim To present a rare case of medication-related osteonecrosis of the jaw (MRONJ) in a patient with acute lymphoblastic leukemia (ALL) who developed the condition during chemotherapy, in the absence of antiresorptive or antiangiogenic therapy, and to describe its successful surgical management.
📊
Key Findings & Data:Case Report A 56-year-old male undergoing chemotherapy for T-cell ALL developed Stage 2 MRONJ during the maintenance phase, despite having no history of antiresorptive or antiangiogenic drug use.
💡
Conclusion & Impact:Surgical management with adjunctive PRF may enhance healing outcomes in such cases.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Acute lymphoblastic leukemia · Chemotherapy · MRONJ

Abstract

Aim To present a rare case of medication-related osteonecrosis of the jaw (MRONJ) in a patient with acute lymphoblastic leukemia (ALL) who developed the condition during chemotherapy, in the absence of antiresorptive or antiangiogenic therapy, and to describe its successful surgical management. Case Report A 56-year-old male undergoing chemotherapy for T-cell ALL developed Stage 2 MRONJ during the maintenance phase, despite having no history of antiresorptive or antiangiogenic drug use. Surgical debridement combined with platelet rich fibrin (PRF) application led to complete clinical healing within four months. Discussion This case emphasizes that MRONJ can occur in hematologic malignancy patients receiving chemotherapy alone. The outcome highlights the importance of considering chemotherapy as a potential risk factor and supports the Conclusion MRONJ should be recognized as a possible complication in patients with ALL undergoing chemotherapy, even without exposure to antiresorptive agents. Surgical management with adjunctive PRF may enhance healing outcomes in such cases.

🔖

Cite This Article

Aydoğmuş, G., Akgül, F. B., Nasiri, E. (2026). Chemotherapy-Associated Osteonecrosis of the Jaw in Acute Lymphoblastic Leukemia: Report of a Rare Clinical Case. Eurasian Dental Research, Volume: 4 Issue: 2. https://doi.org/10.62243/edr.1918505

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. MMalard, F., & Mohty, M. (2020). Acute lymphoblastic leukaemia. The Lancet, 395(10230), 1146–1162.
  2. Shah, B., et al. (2024). Acute lymphoblastic leukemia, version 2.2024, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 22(8), 563–576.
  3. Aldoss, I., Gu, Z., Afkhami, M., Mokhtari, S., & Pullarkat, V. (2023). Ph-like acute lymphoblastic leukemia in adults: Understanding pathogenesis, improving outcomes, and future directions for therapy. Leukemia & Lymphoma, 64(6), 1092–1101.
  4. Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws—2022 update. Journal of Oral and Maxillofacial Surgery, 80(5), 920–943.
  5. AlRowis, R., et al. (2022). Medication-related osteonecrosis of the jaw (MRONJ): A review of pathophysiology, risk factors, preventive measures and treatment strategies. Saudi Dental Journal, 34(3), 202–210.
  6. Ottesen, C., Schiodt, M., & Gotfredsen, K. (2020). Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review. Heliyon, 6(4), e03795.
  7. Marx, R. E., Cillo, J. E., & Ulloa, J. J. (2007). Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. Journal of Oral and Maxillofacial Surgery, 65(12), 2397–2410.
  8. Ali, I. E., & Sumita, Y. (2022). Medication-related osteonecrosis of the jaw: Prosthodontic considerations. Japanese Dental Science Review, 58, 267–273.
  9. Awosika, A. O., Below, J., & Das, J. M. (2026). Vincristine. StatPearls Publishing.
  10. Mergoni, G., et al. (2019). Effects of zoledronic acid and dexamethasone on early phases of socket healing after tooth extraction in rats: A preliminary macroscopic and microscopic quantitative study. Medicina Oral, Patología Oral y Cirugía Bucal, 24(3), e339–e345.
  11. Milosavljević, M., et al. (2022). Possible association of methotrexate use with osteonecrosis of the jaw: Systematic review. Journal of Stomatology, Oral and Maxillofacial Surgery, 123(5), e458–e463.
  12. He, P., Zhang, Q., Motiwala, F. I., Shanti, R. M., Chang, B. M., & Le, A. D. (2022). Potential application of dental stem cells in regenerative reconstruction of oral and maxillofacial tissues: A narrative review. Frontiers in Oral and Maxillofacial Medicine, 4, 14.
  13. Schiodt, M., et al. (2018). A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Supportive Care in Cancer, 26(6), 1905–1915.
  14. Thomas, J. G., & Ouanounou, A. (2023). Medication-related osteonecrosis of the jaw: A narrative review of risk factors, diagnosis, and management. Frontiers in Oral and Maxillofacial Medicine, 5, Article 8.
  15. Frutuoso, F., et al. (2024). Medication-related osteonecrosis of the jaw: A systematic review of case reports and case series. Diseases, 12(9), 205.
  16. Campisi, G., et al. (2020). Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. International Journal of Environmental Research and Public Health, 17(16), 5998.
  17. Ko, Y. Y., Yang, W.-F., & Leung, Y. Y. (2024). The role of cone beam computed tomography (CBCT) in the diagnosis and clinical management of medication-related osteonecrosis of the jaw (MRONJ). Diagnostics, 14(16), 1700.
  18. Salgueiro, M., Stribos, M., Zhang, L. F., Stevens, M., Awad, M. E., & Elsalanty, M. (2019). Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): A retrospective clinical study. EPMA Journal, 10(1), 21–29.
  19. Traboulsi-Garet, B., Jorba-García, A., Camps-Font, O., Alves, F. A., Figueiredo, R., & Valmaseda-Castellón, E. (2022). Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy. Clinical Oral Investigations, 26(3), 2371–2382.
  20. Goker, F., Grecchi, E., Grecchi, F., Francetti, L., & Del Fabbro, M. (2021). Treatment of medication-related osteonecrosis of the jaw (MRONJ): A systematic review. European Review for Medical and Pharmacological Sciences, 25(6), 2662–2673.
  21. Inchingolo, A. M., et al. (2023). MRONJ treatment strategies: A systematic review and two case reports. Applied Sciences, 13(7), 4370.
  22. Cano-Duran, J., Pena-Cardelles, J., Ortega-Concepcion, D., Paredes-Rodriguez, V., Garcia-Riart, M., & Lopez-Quiles, J. (2017). The role of leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of medication-related osteonecrosis of the jaws (MRONJ). Journal of Clinical and Experimental Dentistry, 9(8), e1057–e1065.
  23. Bayram, F., Fattahzade, S., Uzay, A., & Özkan, Y. (2023). Atypical presentation of medication-related osteonecrosis of the jaw in a young male patient undergoing chemotherapy for acute lymphoblastic leukemia. Oral Oncology Reports, 8, 100115.
  24. Wang, L., Huang, J., & Tang, Z. (2022). Chemotherapeutics-induced osteonecrosis of the jaw in a patient with acute promyelocytic leukemia: A rare case report. Oral Oncology, 124, 105659.